FLYSYN in MRD Positive AML
NCT02789254
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
FLYSYN
Sponsor
Synimmune GmbH